Gene editing is at the centre of the next generation of biotechnology. By changing the messages encoded within DNA sequences, it creates new possibilities for researchers to unravel questions ...

Precision BioSciences is a clinical-stage gene-editing company focused on the development of cell and gene therapies to treat cancer and genetic causes of disease. The company’s pipeline of ...

‘Cutting edge’ is, for once, a truly apt description when it comes to gene editing – both because the field is pushing medicine into areas we might never have dreamed possible, and because ...

The Gene Editing & Screening Core Facility (GES Core) brings together complementary technologies aimed at interrogating cancer biology and identifying molecular vulnerabilities of cancer cells. The ...

James and others say that editing mosquitoes with CRISPR—and using a gene drive to make those changes permanent—offers a far better approach. Scientists used conventional genetic engineering ...

Nexiguran ziclumeran (nex-z) is an investigational therapy based on CRISPR-Cas9 (clustered regularly interspaced short palindromic repeats and associated Cas9 endonuclease) targeting the gene ...

No babies have been born with changes made by CRISPR/Cas9 or any other gene-editing technology. But it could be only a matter of time. “I would not be surprised if there were a CRISPR-modified ...

Gene therapy and gene editing are on the cutting edge of modern biotechnology. Gene therapies are used to correct genetic abnormalities by introducing genetic material at a cellular level and can ...

Breakthrough directed evolution system boosts virus-like particles for safer, more efficient gene editing, offering a powerful tool for next-generation therapeutic innovations. Study: Directed ...

Doing CRISPR gene editing while fetuses are in the womb could make it easier to treat inherited conditions, especially those affecting tissues such as the heart or muscles. Kiran Musunuru at the ...

base editing and prime editing, to produce many variants of the EGFR gene. To systematically generate cells with virtually all possible relevant variants of the EGFR gene, Platt and his team first ...